DB
LLY icon

Dmitry Balyasny’s Eli Lilly LLY Stock Holding History

Dmitry Balyasny’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48M Buy
40,000
+16,500
+70% +$16.9M 0.06% 379
2026
Q1 		$21.6M Buy
23,500
+1,400
+6% +$1.42M 0.03% 661
2025
Q4 		$23.8M Sell
22,100
-5,400
-20% -$5.16M 0.03% 630
2025
Q3 		$21M Buy
27,500
+11,000
+67% +$8.19M 0.03% 695
2025
Q2 		$12.9M Sell
16,500
-27,000
-62% -$21M 0.02% 851
2025
Q1 		$35.9M Hold
43,500
– – 0.06% 392
2024
Q4 		$33.6M Buy
43,500
+26,600
+157% +$22M 0.05% 456
2024
Q3 		$15M Buy
16,900
+5,500
+48% +$4.94M 0.02% 764
2024
Q2 		$10.3M Buy
11,400
+1,300
+13% +$1.04M 0.02% 871
2024
Q1 		$7.86M Sell
10,100
-58,700
-85% -$41.8M 0.01% 1038
2023
Q4 		$40.1M Sell
68,800
-304,400
-82% -$178M 0.08% 330
2023
Q3 		$200M Buy
373,200
+152,200
+69% +$78.4M 0.41% 33
2023
Q2 		$104M Buy
221,000
+219,800
+18,317% +$92.2M 0.23% 97
2023
Q1 		$412K Buy
+1,200
New +$405K ﹤0.01% 2005
2022
Q3 		– Sell
-5,000
Closed -$1.62M – 3080
2022
Q2 		$1.62M Buy
+5,000
New +$1.5M 0.01% 1521
2021
Q3 		– Sell
-133,800
Closed -$30.7M – 2208
2021
Q2 		$30.7M Buy
+133,800
New +$26.9M 0.15% 179
2019
Q4 		– Sell
-100,000
Closed -$11.2M – 1345
2019
Q3 		$11.2M Buy
+100,000
New +$11.1M 0.08% 369
2019
Q2 		– Sell
-54,000
Closed -$7.01M – 1623
2019
Q1 		$7.01M Buy
+54,000
New +$6.57M 0.05% 484
2018
Q4 		– Sell
-568,000
Closed -$60.4M – 1582
2018
Q3 		$60.4M Buy
+568,000
New +$56.8M 0.27% 80
2015
Q3 		– Sell
-425,000
Closed -$35.5M – 1281
2015
Q2 		$35.5M Buy
+425,000
New +$32.4M 0.22% 116

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dmitry Balyasny's LLY Position: Q2 2026 in Review

Dmitry Balyasny increased its Eli Lilly (LLY) stake by 752% in Q2 2026, buying an estimated $137M and bringing the position to 151,950 shares worth $182M. The position accounts for 0.23% of the portfolio, ranked #93.

Dmitry Balyasny first reported a position in LLY in Q4 2014 and has held it in 40 quarters since. The position peaked at $390M in Q2 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dmitry Balyasny held 151,950 shares of Eli Lilly worth $182M as of Q2 2026.
  • Dmitry Balyasny bought 134,115 Eli Lilly shares in Q2 2026, an estimated $137M.
  • Eli Lilly made up 0.23% of Dmitry Balyasny's portfolio in Q2 2026, its #93 holding.
  • Dmitry Balyasny first reported a position in Eli Lilly in Q4 2014 and has held it in 40 quarters since.
  • Dmitry Balyasny's Eli Lilly position peaked at $390M in Q2 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.